Sanara MedTech shareholders elect all eight director nominees and ratify auditor at 2023 annual meeting

Sanara MedTech Inc.

7,365,228 shares present at June 1, 2023 meeting; all eight director nominees elected with votes for ranging from 5,512,123 to 5,564,051.
Ratification of Weaver and Tidwell, L.L.P. as auditor for FY 2023: 6,140,532 for, 0 against.
Advisory approval of executive compensation: 5,548,532 for, 24,489 against, 888 abstentions.
All three proposals received sufficient votes to pass.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Sanara MedTech Inc. shareholders approved Election of (i) Ronald T. Nixon, (ii) Robert A. DeSutter, (iii) Roszell Mack III, (iv) Eric D. Major, (v) Sara N. Ortwein, (vi) Ann Beal Salamone, (vii) James W. Stuckert and (viii) Eric D. Tanzberger to the Company’s Board of Directors, each to serve for a one-year term until the annual meeting of at the 2023-06-01 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-06-01

Exact text from the filing

Proposal 1 : Election of (i) Ronald T. Nixon, (ii) Robert A. DeSutter, (iii) Roszell Mack III, (iv) Eric D. Major, (v) Sara N. Ortwein, (vi) Ann Beal Salamone, (vii) James W. Stuckert and (viii) Eric D. Tanzberger to the Company’s Board of Directors, each to serve for a one-year term until the annual meeting of shareholders to be held in 2024 or until his or her successor is elected and qualified. Nominee Votes Cast For Votes Withheld Broker Non-Votes Ronald T. Nixon 5,547,819 0 1,817,409 Robert A. DeSutter 5,512,123 60,898 1,792,207 Roszell Mack III 5,556,796 16,225 1,792,207 Eric D. Major 5,556,796 16,225 1,792,207 Sara N. Ortwein 5,556,621 16,400 1,792,207 Ann Beal Salamone 5,555,763 17,258 1,792,207 James W. Stuckert 5,564,051 8,970 1,792,207 Eric D. Tanzberger 5,556,821 16,200 1,792,207

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Sanara MedTech Inc. shareholders approved Ratification of the appointment of Weaver and Tidwell, L.L.P. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. at the 2023-06-01 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-06-01

Exact text from the filing

Proposal 2 : Ratification of the appointment of Weaver and Tidwell, L.L.P. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. Votes Cast For Votes Cast Against Abstentions 6,140,532 0 0

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Sanara MedTech Inc. shareholders approved Approval, on an advisory basis, of the compensation of the Company’s named executive officers. at the 2023-06-01 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2023-06-01

Exact text from the filing

Proposal 3 : Approval, on an advisory basis, of the compensation of the Company’s named executive officers. Votes Cast For Votes Cast Against Abstentions Broker Non-Votes 5,548,532 24,489 888 1,791,319

View on SEC.gov

553 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Sanara MedTech Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-020279

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.